229 related articles for article (PubMed ID: 1378455)
1. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.
Kronborg G; Fomsgaard A; Galanos C; Freudenberg MA; Høiby N
J Clin Microbiol; 1992 Jul; 30(7):1848-55. PubMed ID: 1378455
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
3. Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis.
Kronborg G; Pressler T; Fomsgaard A; Koch C; Høiby N
Infection; 1993; 21(5):297-302. PubMed ID: 8300245
[TBL] [Abstract][Full Text] [Related]
4. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.
Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR
J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Fomsgaard A; Høiby N; Shand GH; Conrad RS; Galanos C
Infect Immun; 1988 Sep; 56(9):2270-8. PubMed ID: 3410536
[TBL] [Abstract][Full Text] [Related]
6. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.
Schiøtz PO; Høiby N; Permin H; Wiik A
Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981
[TBL] [Abstract][Full Text] [Related]
7. Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Fomsgaard A; Dinesen B; Shand GH; Pressler T; Høiby N
J Clin Microbiol; 1989 Jun; 27(6):1222-9. PubMed ID: 2502558
[TBL] [Abstract][Full Text] [Related]
8. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.
Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E
Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.
Pedersen SS; Espersen F; Høiby N; Jensen T
J Clin Microbiol; 1990 Apr; 28(4):747-55. PubMed ID: 2110181
[TBL] [Abstract][Full Text] [Related]
10. Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis.
Pham A; Ledger EL; Coggon CF; Henderson IR; Reid DW; Bell SC; Smith DJ; Wells TJ
Infect Immun; 2021 Nov; 89(12):e0041221. PubMed ID: 34460286
[TBL] [Abstract][Full Text] [Related]
11. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
[TBL] [Abstract][Full Text] [Related]
12. Distribution of antibodies to selected antigens of Pseudomonas aeruginosa in children and young adults with cystic fibrosis.
Gaweł J; Pogorzelski A; Działek-Smętek E; Sochań B; Ligarska R; Lącka M; Mazurek H
Pneumonol Alergol Pol; 2014; 82(4):336-41. PubMed ID: 24964236
[TBL] [Abstract][Full Text] [Related]
13. A specific serum IgA antibody discriminates pneumonia from colonization state in patients with Pseudomonas aeruginosa in sputum culture.
Yamashita M; Hida Y; Sugimoto H; Takahashi N; Kimura H; Nakatomi Y; Yoshida H; Ishizaki T
J Microbiol Methods; 2010 Sep; 82(3):198-204. PubMed ID: 20538018
[TBL] [Abstract][Full Text] [Related]
14. Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis.
Weisner AM; Chart H; Bush A; Davies JC; Pitt TL
J Med Microbiol; 2007 May; 56(Pt 5):670-674. PubMed ID: 17446292
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in serum and sputum from patients with cystic fibrosis.
Schiøtz PO; Egeskjold EM; Høiby N; Permin H
Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
[TBL] [Abstract][Full Text] [Related]
16. Significance of immunologic factors in cystic fibrosis.
Przyklenk B; Bauernfeind A
Scand J Gastroenterol Suppl; 1988; 143():103-9. PubMed ID: 2455329
[TBL] [Abstract][Full Text] [Related]
17. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.
Brauner A; Cryz SJ; Granström M; Hanson HS; Löfstrand L; Strandvik B; Wretlind B
Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):430-6. PubMed ID: 8359163
[TBL] [Abstract][Full Text] [Related]
19. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
Moss RB; Hsu YP; Lewiston NJ; Curd JG; Milgrom H; Hart S; Dyer B; Larrick JW
Am Rev Respir Dis; 1986 Apr; 133(4):648-52. PubMed ID: 3083745
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis.
Pedersen SS; Møller H; Espersen F; Sørensen CH; Jensen T; Høiby N
APMIS; 1992 Apr; 100(4):326-34. PubMed ID: 1581041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
